Tohru Takemasa
Papers
2
Total Citations
4
H-Index
2
About
Tohru Takemasa is a pioneering researcher at the forefront of biotechnology and anti-doping science, with a primary focus on gene doping detection and veterinary genetics. His most notable contribution is the development of a groundbreaking detection method that combines dried blood spot sampling with next-generation sequencing and the LabDroid automated system, published in 2025. This innovative approach addresses the critical challenge of identifying gene therapy misuse in sports—a rapidly emerging threat as gene therapies become more accessible. By creating a practical, sensitive, and automated testing protocol, Takemasa’s work directly strengthens the integrity of athletic competition, offering a scalable solution to a problem that current methods struggle to address. In parallel, his 2024 study on whole mitochondrial DNA sequencing from canine fecal samples demonstrates his versatility, advancing non-invasive genetic monitoring for domestic dog welfare. Though his citation counts are currently modest (2 each), these early papers signal high-impact, translational research. Takemasa’s work is particularly notable for its forward-looking application of cutting-edge genomic tools to real-world regulatory and veterinary challenges, positioning him as a key figure in the future of doping control and animal health genomics.
Research Focus
Key Achievements
Top Papers
- 1
- 2